ArticleScientific reports2026
Prevalence of indication for lateral approach sinus floor augmentation in maxillary molar tooth deficiency: a retrospective study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This retrospective study aimed to evaluate the frequency of lateral approach sinus floor augmentation (LASFA) in patients missing at least one maxillary molar, based on assessments of residual vertical bone height (RVBH) and maxillary sinus anatomy using cone-beam computed tomography (CBCT). A total of 402 CBCT scans meeting the inclusion criteria were analyzed, encompassing 458 maxillary sinuses. The RVBH was measured on ten equidistant mesiodistal slices beneath the maxillary sinus, and the mean value was recorded as the RVBH for each site. Patients were divided equally by sex and into four age groups (18-28, 29-39, 40-50, and > 50 years). Those with RVBH ≤ 5 mm were classified as requiring LASFA, and those with RVBH > 5 mm as not requiring the procedure. LASFA was indicated in 28.2% of patients, whereas 71.8% did not require it. The mean RVBH was 7.68 ± 3.69 mm (range: 1.31-19.73 mm). Age distribution showed no significant difference between groups (p = 0.714), whereas gender distribution did (p = 0.017), with a higher proportion of males requiring LASFA (58.9%) compared with females (41.1%). Within the study limitations, a substantial proportion of patients with maxillary molar tooth deficiency required LASFA. While RVBH exhibited a slight downward trend with advancing age, it was found to be higher in males than in females. These findings highlight the critical importance of pre-operative RVBH assessment via CBCT to ensure precise surgical planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.